Baxfendy Tablet, Film Coated
Product Images NDC 0310-6001

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Baxfendy (NDC 0310-6001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Astrazeneca Pharmaceuticals Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1mg_30count_bottle_label (1mg 30count Bottle Label)

BAXFENDY (baxdrostat) 1 mg film-coated tablets label from AstraZeneca Pharmaceuticals LP. The label indicates oral tablet form with instructions to swallow whole, not cut or crush. Contains 30 tablets per container with storage guidance to use original container with desiccant. Includes NDC 0310-6001-30 and various regulatory and compliance information.*

FDA Label Image

2mg_30_count_bottle_label (2mg 30 Count Bottle Label)

Packaging label for BAXFENDY (baxdrostat) 2 mg film-coated tablets by AstraZeneca Pharmaceuticals LP. The carton contains 30 tablets with instructions to swallow whole, not to cut, crush, or chew. Storage guidance includes keeping the tablets at 20°C to 25°C with protection from moisture.*

FDA Label Image

Figure_1 (Figure 1)

A line graph showing change from baseline in seated systolic blood pressure (SBP) over 12 weeks for baxdrostat 1 mg, baxdrostat 2 mg, and placebo groups. The y-axis represents change in SBP in mmHg, with values decreasing to about -18 mmHg. The x-axis shows time points at baseline, week 4, week 8, and week 12. Both baxdrostat doses show a marked decrease in SBP compared to placebo, which shows a smaller decrease over time. Error bars indicate 95% confidence intervals for least squares means. Patient numbers for each group at each time point are listed below the graph.*

FDA Label Image

Baxdrostat_structural_formula (Baxdrostat Structural Formula)

Chemical structure diagram of baxdrostat, the active ingredient in BAXFENDY tablets. The diagram shows the molecular composition including ring structures and functional groups characteristic of this compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.